Umbilical Cord Mesenchymal Stem/Stromal Cells and Low-Dose Obeticholic Acid as a Possible Combined Treatment for Liver Fibrosis

Stem Cell Rev Rep. 2022 Jun;18(5):1875-1877. doi: 10.1007/s12015-022-10346-8. Epub 2022 Feb 4.

Ahmed Lotfy¹, Shimaa El-Metwaly², Reham Soliman^{2

3}, Ayman A Hassan², Gamal Shiha^{4

5}

¹ Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, 62511, Egypt. Lotfy_bio@hotmail.com.
² Egyptian Liver Research Institute and Hospital (ELH), Mansoura, Egypt.
³ Tropical Medicine Department, Faculty of Medicine, Port Said University, Port Said, Egypt.
⁴ Egyptian Liver Research Institute and Hospital (ELH), Mansoura, Egypt. G_shiha@hotmail.com.
⁵ Hepatology and Gastroenterology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt. G_shiha@hotmail.com.

No abstract available

Keywords: Liver Fibrosis; Mesenchymal Stem/Stromal Cells; Obeticholic acid.

Publication types